| Authors: |
Howell BA; Section of General Medicine, Yale School of Medicine, New Haven, CT, United States; Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, United States. Electronic address: benjamin.howell@yale.edu., Black A; Section of General Medicine, Yale School of Medicine, New Haven, CT, United States., Lin HJ; Connecticut Department of Mental Health and Addiction Services, Hartford, CT, United States; School of Social Work, University of Connecticut, Hartford, CT, United States., Liberatore MA; Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States., Greene CR; Division of Epidemiology (DEPI-II), Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States., D'Onofrio G; Department of Emergency Medicine, Yale School of Medicine, New Haven, CT, United States., Heimer R; Yale School of Public Health, New Haven, CT, United States., Grau LE; Yale School of Public Health, New Haven, CT, United States., Hawk K; Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, United States; Department of Emergency Medicine, Yale School of Medicine, New Haven, CT, United States., Fiellin DA; Section of General Medicine, Yale School of Medicine, New Haven, CT, United States; Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, United States; Yale School of Public Health, New Haven, CT, United States., Becker WC; Section of General Medicine, Yale School of Medicine, New Haven, CT, United States; Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, United States. |
